BMJ 2008; 337 doi: 10.1136/bmj.a2457 (Published 11 November 2008)
Cite this as: BMJ 2008;337:a2457

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

When Clostridium difficile was first identified in 1935, in the stools of healthy neonates, it was named Bacillus difficilis by its discoverers. They chose the specific name difficilis to reflect the difficulty they had had in isolating and culturing the organism. It’s ironic that the label is still appropriate, now that controlling the growth and spread of this bacterium is the problem (NEJM 2008; 359:1932-40, doi:10.1056/NEJMra0707500).

In the 1980s, the genital variant of herpes simplex virus was seen as a new and threatening sexually transmitted disease. As an editorial in Sexually Transmitted Infections (2008;84:330-1, doi:10.1136/sti.2008.032003) remarks, it even made the cover of Time magazine. This threat was rapidly eclipsed by that of HIV, and the focus of research changed. Even now, evidence about risks and harms of screening for genital herpes infection is inadequate to formulate a rational public health policy.

Everyone agrees that new …

Access to the full text of this article requires a subscription or payment

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL